Occult etiologies of complete atrioventricular block: Report of two cases  by Bachani, Neeta et al.
Indian Heart Journal 68 (2016) S186–S189
Contents lists available at ScienceDirect
Indian Heart Journal
journal homepage: www.e lsev ier .com/ locate / ih jCase ReportOccult etiologies of complete atrioventricular block: Report of two
cases
Neeta Bachani a, Gopi Krishna Panicker b, Jaipal Jadwani a, Yash Lokhandwala c,*
aHoly Family Hospital, Mumbai, India
bQuintiles Cardiac Safety Services, Mumbai, India
cArrhythmia Associates, Mumbai, IndiaA R T I C L E I N F O
Article history:
Received 11 March 2016
Accepted 27 July 2016





A B S T R A C T
In patients presenting with complete atrioventricular (AV) block, the common causes are degeneration
of the conduction system, acute myocardial infarction, congenital and metabolic disorders (such as
azotemia). However, at times, no cause can be ascribed and the label congenital or degenerative is
applied depending on the patient’s age and the QRS complex width. We present two cases of patients
with complete AV block, who were subsequently found to have rare etiologies – sarcoidosis (with
isolated feature of AV block) and non-Hodgkin’s lymphoma.
 2016 Cardiological Society of India. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Complete atrioventricular (AV) block is regarded as a serious
condition requiring prompt therapy. Studies evaluating its
incidence and prevalence amongst patients with known heart
disease and screening of normal cohorts conﬁrm that the most
common causes of complete AV block are degeneration of the
conducting system, congenital, acute myocardial infarction and
metabolic disorders (such as azotemia). However, in a signiﬁcant
number of cases, no speciﬁc cause can be ascribed and a congenital
or degenerative cause is inferred based on the patient’s age and the
QRS complex width. We present two cases in which the patients
had complete AV block due to rare etiologies.
2. Case 1
A 30-year-old man of Indian origin without any comorbidities
was admitted in a hospital in Dubai with a history of unexplained
giddiness and chest heaviness since 1 day. The ECG showed a
complete AV blockwith awideQRS escape rhythm (Fig. 1a) and the
patient underwent temporary transvenous pacing along with
supportive therapy (atropine/dopamine/IV ﬂuids). The troponin I
evaluation showed an increasing trend for 2 days and then it
decreased. The echocardiogram was normal. The escape rhythm* Corresponding author at: 502 A, Leela Business Park, M.V. Road, Andheri (East),
Mumbai 400 059, India.
E-mail address: yashlokhandwala@hotmail.com (Y. Lokhandwala).
http://dx.doi.org/10.1016/j.ihj.2016.07.018
0019-4832/ 2016 Cardiological Society of India. Published by Elsevier B.V. This is an
licenses/by-nc-nd/4.0/).gradually changed with the QRS becoming relatively narrow
(Fig. 1b) and after 4 days the AV conduction recovered, albeit with a
prolonged PR interval of 240 ms. The pacing electrode was
withdrawn and the patient was discharged.
The patient subsequently came to Mumbai and was referred to
the hospital for further evaluation. The coronary angiogram
evaluation was normal while a cardiac MRI evaluation showed
mid-myocardial scarring along with inﬂammatory changes in the
basal septalmyocardium (Fig. 2); therewas signiﬁcantmediastinal
and hilar adenopathy with sub-pleural and peri-bronchovascular
nodules. Overall, these ﬁndings suggested sarcoidosis with cardiac
involvement. Further work-up showed the following: SGOT-42 IU/
l, SGPT 82 IU/l, Serum calcium 9.6 mg%, ESR 16 andmildly elevated
ACE level of 58mg/l. The Mantoux test was negative.
A CT-guided sub-pleural lymph node biopsy revealed non-
necrotizing granulomatous inﬂammation of undetermined etiolo-
gy. A 24-h Holter showed no evidence of AV block and an average
HR of 72 bpm. The patient was started on oral prednisolone 40 mg
once a day. Over the next 2 weeks his PR interval normalized;
prednisolone was then tapered off. At 3 months follow-up, he is on
prednisolone 5 mg daily and his ECG remains normal.
3. Case 2
A 68-year-old man had been diagnosed to have idiopathic
thrombocytic purpura (ITP) since 2012 and had undergone
splenectomy after inadequate response to medical therapy. Eight
months after the surgery, the patient started again havingopen access article under the CC BY-NC-ND license (http://creativecommons.org/
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Fig. 1. (a) ECG on presentation. Sinus tachycardia, complete AV block, wide QRS escape rhythm. (b) Sinus tachycardia and complete AV block persist, but the escape rhythm
shows relatively narrow QRS complexes (IRBBB).
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was re-evaluated by a hematologist and started on Eltrombopag
(Revoled), which was used intermittently as per the platelet count.
The patient was admitted in November 2014 for fever after
getting repeated bouts of fever with thrombocytopenia. The
etiology of fever could not be established following an extensive
work-up including echocardiography and whole body PET CT scan.
However, the patient responded to broad-spectrum antibiotics and
was subsequently discharged.
The patient was admitted in March 2015, for weakness and
giddiness and was found to have complete AV block with a narrow
QRS escape rhythm. Initially a conservative therapeutic approach
was adopted since there appeared to be a stable ventricular rate of
40 beats/min. A repeat echocardiogram was normal. Since the
rhythmdid not settle over 7 days, an AV sequential pacemaker was
implanted.
The patient was the re-admitted in May 2015 with fever and
thrombocytopenia. As a part of work up for identifying the cause of
the fever, the patient again underwent an echocardiography,
which surprisingly revealed a large echo-dense mass attached to
the left atrial wall above the mitral annulus. There was also a largeecho-dense mass in the AV groove (Fig. 3a), which was seen
extending outwards on both sides. Therewas also inﬁltration of the
interatrial septum and interventricular septum (Fig. 3b) alongwith
a small pericardial effusion. The cardiac CT evaluation revealed
encasement of proximal right and left coronary arteries; the mass
also invaded the central ﬁbrous body area and eroded the left atrial
wall, thence protruding into its cavity (Fig. 4).
The whole body PET CT scan was repeated which showed: Active disease demonstrating high grade metabolic activity
involving soft tissue nodular masses in the interatrial septum
and left atrium extending into mitral valve, interventricular
septum, aorto-pulmonary recess and along posteriorwall of right
atrium. Metabolically active nodular soft tissue lesions in abdomino-
pelvic region. Focal inﬂammatory activity involving wall thickening of
abdominal aorta.
A CT-guided biopsy of the peritoneal deposit showed non-
Hodgkin’s lymphoma (NHL) of T cell variety.
[(Fig._2)TD$FIG]
Fig. 2. CardiacMRI: phase sensitive inversion recovery image taken in the short axis
plane shows septal scar (solid black arrow) as an area of persistent enhancement at
15 min delayed post-contrast imaging. LV, left ventricle; RV, right ventricle.
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Fig. 3. (a) Apical 4 chamber view. Mass (M) along the AV groove. LV, left ventricle;
RV, right ventricle; RA, right atrium; PE, pericardial effusion. (b) Parasternal long
axis view. Masses seen around the mitral annulus and interventricular septum; LA,
left atrium; Ao, aorta.
[(Fig._4)TD$FIG]
Fig. 4. Cardiac CT scan image showing the mass around the aortic root and invading
the left atrial wall.
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In patients with symptomatic AV block, permanent pacing is
needed unless there is a reversible cause, such as inferior wall
myocardial infarction or metabolic disturbance. These are usually
easily diagnosed. Even viral myocarditis would be picked up on
echocardiography. As seen in our patient, sarcoidosis would have
been missed, if not thought of and assiduously looked for.
The common organs involved in sarcoidosis include lymph
nodes, skin, lungs and eye. The heart is involved in up to 30% of
patients with sarcoidosis.1 Only 40–50% of patients with cardiac
sarcoidosis diagnosed at autopsy have the diagnosis made during
their lifetime. Cardiac sarcoidosis can manifest itself as AV block,
ventricular arrhythmias, heart failure, pericardial effusion, pulmo-
nary hypertension and ventricular aneurysms. Presentation with
symptomatic AV block is rare and is seen in less than 2% of patients.
The mechanism is either involvement of the interventricular
septum or of the AV nodal artery. Complete AV block is considered
a high-risk category with the prognosis depending on the site of
the block. If the site of block is the AV node, the escape rhythmmay
recover; the AV block in this setting may respond to vagolytic or
adrenergic drugs. If the site of the block is the His bundle or the
right or left bundle branches, then it is less likely to be reversible
and is associated with higher risk of ventricular ﬁbrillation, heart
failure and increased mortality. Pacemaker implantation is the
only reasonable treatment when reversible causes cannot be
identiﬁed.
Cardiac involvement in malignancy is more commonly
secondary and the pericardium is the commonest location.2 These
are usually obvious at echocardiography. In our patient, the unique
feature was that the septal involvement which led to AV block was
not apparent at initial presentation. Primary cardiac lymphomas
are often Hodgkin’s variety of lymphoma. In this case, the patient
was assessed as having primary NHL (extra-cardiac involvement
was minimal) and the mass possibly started from area of central
ﬁbrous body, which clinically manifested as complete AV block.
Eltrombopag is a thrombopoeitin receptor agonist. It improves the
platelet count stimulating the cascade of megakaryocytes forma-
tion and differentiation. The US FDA approved eltrombopag in
2008 for Immune/idiopathic thrombocytopenia purpura with
inadequate response to steroids, immunotherapy, immunoglobu-
lins and/or splenectomy. It is supposed to be used intermittently to
improve platelet count >50,000/mm.3 A recently concluded
‘‘EXTEND’’ trial has proven its efﬁcacy and safety in long-term
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with long term use. In an evaluation of 419 patient years of long-
term use (>2 years), 2 patients developed lymphoma.4 Our patient
used eltrombopag continuously for more than 14 months. The
dilemma remains whether the NHL was incidental or was related
to prolonged use of eltrombopag.
In conclusion, one must be alert for unusual etiologies of AV
block, especially when there is a ﬂuctuant course or atypical
presentation. This would allow for disease modifying treatment
and sometimes eliminate the need for pacing.
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